Insight journal, Insight journal - Company

NPS Pharmaceuticals: Big biotech partnering trends 2009-2014

Posted on 21 August 2014

Tags: ,

NPS Pharmaceuticals is a US based specialty company. The company mainly focuses its efforts to treat rare diseases worldwide. 

The company’s product pipeline that includes Gattex, Natpara treats short bowel syndrome and hypoparathyroidism respectively. The company seeks partners to out license its products for a global coverage.

Since 2009 NPS Pharmaceuticals announced 7 partnering / licensing deals. This partnering review article of NPS Pharmaceuticals provides an understanding of the therapeutic areas of interest of the big biotech company, its technology focus areas, partners of interest and much more.

Abstracted from: Partnering Agreements with NPS Pharmaceuticals 2009-2014

As you can observe, NPS Pharmaceuticals has not been very active in the partnering area since 2009. In 2009, the company the company entered into manufacturing agreements with Hospira, Synco Bio Partners and Vetter for Gattex and Natpara.

The following figure shows the level of NPS Pharmaceuticals partnering deal announcements since 2009.

Figure 1: NPS Pharmaceuticals partnering deals 2009-2014

Figure 1: NPS Pharmaceuticals partnering deals 2009-2014

Figure 1: NPS Pharmaceuticals partnering deals 2009-2014

Source: Current Agreements, 2014

NPS Pharmaceuticals has partnered products to treat thyroid disease, hyperthyroidism and other gastrointestinal diseases. The company is on the lookout for partners to out-license products for strategic breakthroughs.

The following table provides an overview of the partnering deals announced by NPS Pharmaceuticals based on therapy area disclosed. The popular therapy area for NPS Pharmaceutical’s partnering is gastrointestinal, specifically irritable bowel disease and syndrome. Our report provides a more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with NPS Pharmaceuticals 2009-2014

Figure 2: NPS Pharmaceuticals partnering deals by therapy area 2009-2014

Figure 2: NPS Pharmaceuticals partnering deals by therapy area 2009-2014

Figure 2: NPS Pharmaceuticals partnering deals by therapy area 2009-2014

Source: Current Agreements, 2014

Further analysis of these deals shows that NPS Pharmaceuticals has a preference for manufacturing and supply deals. This is in parallel with the company’s mission statement to partner for out-licensing opportunities and market late stage products.

Our report Partnering Agreements with NPS Pharmaceuticals 2009-2014 provides a better understanding of the deals captured.

The following table provides an overview of the partnering deals announced by NPS Pharmaceuticals based on deal type disclosed.

Figure 3: NPS Pharmaceuticals partnering deals by deal type 2009-2014

Figure 3: NPS Pharmaceuticals partnering deals by deal type 2009-2014

Figure 3: NPS Pharmaceuticals partnering deals by deal type 2009-2014

Source: Current Agreements, 2014

When looking at stage of development at partnering deal signing, the most popular stages at signing are marketed stage deals.

The following table provides an overview of the partnering deals announced by NPS Pharmaceuticals based on stage of development at signature.

Figure 4: NPS Pharmaceuticals partnering by stage of development 2009-2014

Figure 4: NPS Pharmaceuticals partnering by stage of development 2009-2014

Figure 4: NPS Pharmaceuticals partnering by stage of development 2009-2014

Source: Current Agreements, 2014

NPS Pharmaceuticals has signed 7 partnering, collaborative R&D and licensing deals since 2009. The following provides a summary of the top deals by headline value.

Figure 5: Top NPS Pharmaceuticals partnering deals by headline value 2009-2014

Figure 5: Top NPS Pharmaceuticals partnering deals by headline value 2009-2014

Figure 5: Top NPS Pharmaceuticals partnering deals by headline value 2009-2014

Source: Current Agreements, 2014

Our report provides a more detailed insight into the details of each deal. See: Partnering Agreements with NPS Pharmaceuticals 2009-2014

NPS Pharmaceuticals partnering at Current Agreements

View all partnering deals for NPS Pharmaceuticals:  2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at Current Agreements (subscription required)

Or purchase report: Partnering Agreements with NPS Pharmaceuticals 2009-2014

More   

Summary profile data for NPS Pharmaceuticals

Partnering interests for NPS Pharmaceuticals

No M&A activity for NPS Pharmaceuticals                                 

 

Available reports from Current Partnering

Report: Partnering Agreements with NPS Pharmaceuticals 2009-2014 

Report: Partnering Deals and Alliances with Big Biotech

Report: Big Biotech Partnering Yearbook 2013

Available resources for deal coverage for NPS Pharmaceuticals 

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on NPS Pharmaceuticals company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Finding Biopharma Licensing and Collaboration Partners

View: Current Partnering Insight Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering Insight M&A Scorecard – view top life science M&A deals by value

View: Current Partnering Insight Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering Insight Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Insight Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Insight Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter 

Print Friendly, PDF & Email

Leave a Reply